NCT04614571View on ClinicalTrials.gov

T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions

Celiac Disease

Interventions

DIETARY_SUPPLEMENT

Gluten Powder

Administered orally daily for 14 days

Trial Locations (1)

02114

Celiac Research Centre Mass General Hospital, Boston

All Listed Sponsors

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT04614571 - T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge | Biotech Hunter | Biotech Hunter